Image of Flash
  • Industry News
  • Proveris News
  • What's On Your Mind?

Successful deployments of Proveris solutions globally catapult record performance and revenue for 2008!

8 May 2009| Archimedes Pharma Limited announces ground breaking Phase III data showing Nasalfent to be superior to the standard of care for breakthrough cancer pain.  More

9 March 2009| Schering-Plough Corporation announces that its Board of Directors has unanimously approved a definite merger agreement under which Merck and Schering-Plough will combine, under the name Merck, in a stock and cash Transaction. More

2 March 2009| Intranasal Therapeutics, Inc. changes name to Ikano Therapeutics and completes $9 million series B financing. More


The second generation of Proveris's Indizo® high through-put robotic measurement instrument is available.


25 February 2009| European Patent Office allowed a key patent covering the core methodology embedded in Proveris's SprayVIEW® instruments.

17 February 2009| Patent No. 7,490,782 issued by the U.S. Patent and Trademark Office covering novel device holders used in Proveris's Vereo® actuation instruments.

13 February 2009| Patent No. 228992 issued by the Indian Patent Office covering the core technology embedded in Proveris's Vereo® actuation instruments.

 

  • Executive
    • How can Proveris improve the bottom line? By accelerating the success of your spray or aerosol drug product.
      More
  • Laboratory
    • How can Proveris help streamline spray and aerosol drug tests? By pioneering and providing the automated technology now recommended and used by the FDA.
      More
  • Information Technology
    • How can Proveris unify global, corporate enterprises? By integrating spray and aerosol test data within your secured network.
      More
  • Quality Control
    • How can Proveris help with quality control? By providing a spray and aerosol drug test platform premised on regulatory compliance and reliability.
      More

Certified to
ISO9001:2000 by: